RxDoctor Payments Data

Yasir Al-Khalili, MD

Neurology · South Hill, VANPI 1730528159

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Johnson & Johnson at 56.5% of the total. 2025 is the largest year on record at $75,505, more than ten times the $1,988 reported in 2019. Among neurology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$81,140in general payments, 2019–2025

Across 194 payments — averaging $418.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$46K
  • Amgen$16K
  • Argenx US, Inc.$13K
  • Medtronic$2K
  • AstraZeneca$1K
  • UCB, Inc.$811
  • plus $2K from 12 others

What the payments were for

  • Consulting fees$14,59918%
  • Speaking & faculty fees$41,91352%
  • Travel & lodging$15,52119%
  • Food & beverage$9,10711%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$81,140 in reported general payments places this provider in the 90th percentile of 474 neurology providers in Virginia.

See all neurology providers in Virginia

Medicare billing

Part B allowed, 2024
$87,168
Medicare patients
309
Services billed
742

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5012$240,227
Azathioprine12$2,615
Carbamazepine ErCarbamazepine15$1,858
Pyridostigmine Bromide17$1,709
Duloxetine Hcl43$1,251
Levetiracetam32$981
Carbidopa-LevodopaCarbidopa/Levodopa20$807
Oxcarbazepine12$603
Lamotrigine23$476
Donepezil Hcl22$450
Topiramate21$385
Baclofen13$349
Primidone13$327
Gabapentin19$320
Memantine Hcl14$318

Paid to pharmacies, not to this prescriber.

Other neurology in South Hill

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →